Document Detail

Prognosis investigation in patients with chronic heart failure and pericardial effusion.
MedLine Citation:
PMID:  22490591     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Researchers still do not reach the consensus on the incidence, characters and the prognostic value of pericardial effusion (PE) in patients with chronic heart failure (CHF). This study is to investigate the incidence, characters and the prognostic value of pericardial effusion (PE) in patients with CHF.
METHODS: One thousand one hundred and eighty-nine patients, with a diagnosis of CHF consecutively admitted to three centers, were enrolled. M-mode echocardiography was used to determine the presence or absence of PE and to semi-quantify it. The 118 patients with PE and 472 without PE were followed up. The relationship between the PE and other parameters and the prognostic value of PE for CHF were analyzed by univariate and multivariate analyses.
RESULTS: After following up, 550 patients were analyzed, of which 226 were dead. The incidence of PE was 9.92%. Moderate PE was the most common which account 90.68% (107/118). The 6.78% of the patients (8/118) had small while only 2.54% (3/118) had large one. The systolic blood pressure (OR = 1.04, 95%CI (1.01 - 1.07), P = 0.08), left ventricular ejection fraction (LVEF) (OR = 1.09, 95%CI (1.02 - 1.15), P = 0.06), and main pulmonary artery diameter (MPAD) (OR = 1.51, 95%CI (1.24 - 1.85), P < 0.001) were the independent predictors of PE. The glomerular filtration rate (GFR) (OR = 1.013, 95%CI (1.005 - 1.026), P = 0.02), systolic blood pressure (OR = 1.02, 95%CI (1.00 - 1.03), P = 0.015), LVEF (OR = 1.08, 95%CI (1.04 - 1.12), P < 0.001) and diabetes mellitus (OR = 3.53, 95%CI (1.99 - 6.44), P < 0.001) were determined as the independent predictors of CHF prognosis.
CONCLUSIONS: The PE is not uncommon in CHF patients and most PE are small to moderate. PE is not related to the etiology of CHF while is strongly connected with higher systolic blood pressure, low LVEF and large MPAD. PE dose not increase the risk of death in patients with CHF.
Sheng-Bo Yu; Qing-Yan Zhao; He Huang; Dong-E Chen; Hong-Ying Cui; Mu Qin; Cong-Xin Huang
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chinese medical journal     Volume:  125     ISSN:  0366-6999     ISO Abbreviation:  Chin. Med. J.     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-04-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7513795     Medline TA:  Chin Med J (Engl)     Country:  China    
Other Details:
Languages:  eng     Pagination:  882-7     Citation Subset:  IM    
Cardiovascular Research Institute of Wuhan University, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Up-regulation of visfatin expression in subjects with hyperthyroidism and hypothyroidism is partiall...
Next Document:  Inhibition of integrin-linked kinase by angiotensin II receptor antagonist, irbesartan attenuates po...